Across Europe, people are living longer, a trend reflected in rising life expectancy rates. However, this progress isn’t uniform. Significant disparities persist, influenced by factors ranging from gender and socioeconomic conditions to geographical location and access to healthcare. While the overall European average continues to climb, a closer look reveals a complex picture of longevity, with some regions and demographics enjoying considerably longer lifespans than others. Understanding these variations is crucial for crafting effective public health policies and ensuring equitable access to the conditions that support a long and healthy life.
Recent data indicates a positive trajectory in life expectancy across the European Union. In 2024, the average life expectancy reached 81.5 years, a slight increase of 0.1 years compared to the previous year and exceeding the pre-pandemic level of 81.3 years recorded in 2019. This rebound follows a dip to 80.1 years in 2021, at the height of the COVID-19 pandemic, highlighting the pandemic’s temporary but significant impact on population health. The World Health Organization (WHO) continues to emphasize the effectiveness of up-to-date vaccines in mitigating severe illness and death from COVID-19, contributing to the stabilization and gradual increase in life expectancy figures. European regulators recently recommended approval of a combined mRNA vaccine for both influenza and COVID-19, a development expected to further bolster public health defenses.
The Gender Gap in Longevity
A consistent pattern observed across Europe is the significant difference in life expectancy between women and men. On average, women in Europe live approximately 5.2 years longer than men, with a life expectancy of 84.1 years in 2024 compared to 78.9 years for men. This disparity is not new, but the data reveals a slight shift in recent years. While women continue to outlive men, the increase in life expectancy in 2024 was marginally higher for men (+0.2 years) than for women (+0.1 years). This suggests a narrowing, albeit slow, of the gender gap. The reasons for this difference are multifaceted, encompassing biological factors, lifestyle choices, and varying levels of risk-taking behavior.
The smallest gender gaps in life expectancy are found in the Netherlands (2.8 years), Sweden (3.1 years), and Ireland (3.4 years). In Sweden, women can expect to live 85.3 years, while men have a life expectancy of 82.3 years. Similarly, in Denmark, women’s life expectancy is 83.9 years compared to 80.2 years for men, and in Norway, it’s 84.8 years for women and 81.6 years for men. These Nordic countries consistently demonstrate a commitment to gender equality and robust social welfare systems, which likely contribute to the smaller disparities in longevity.
Where in Europe Do People Live the Longest?
When looking at national averages, Switzerland and Spain stand out as countries where people live the longest. In 2024, life expectancy in Spain was 84 years, while in Switzerland – which is not a member of the EU – it was even higher, at 84.2 years. Several other European nations also boast above-average life expectancies, including Sweden (83.8 years), Italy (83.7 years), Norway (83.2 years), France (83 years), Austria (82.1 years), and Denmark (82 years). Germany’s life expectancy is slightly below the EU average, at 81.2 years.
However, the picture becomes even more nuanced when examining regional variations. Four regions consistently demonstrate the highest life expectancies: Madrid in Spain (85.7 years), the provinces of Trento and Bolzano in Italy, and the Stockholm region in Sweden (all at 85 years). These areas often benefit from high-quality healthcare systems, favorable environmental conditions, and strong socioeconomic indicators. Conversely, the lowest life expectancies are recorded in three Bulgarian regions (ranging from 73.9 to 75.4 years), France’s overseas department of Mayotte (74.5 years), and Hungary’s Észak-Magyarország region (75.1 years). These regions often face challenges related to poverty, limited access to healthcare, and environmental pollution.
The Impact of the COVID-19 Pandemic and Excess Mortality
The COVID-19 pandemic had a demonstrable impact on life expectancy across Europe, as evidenced by the decline in 2021. Research from EuroMOMO highlights the extent of excess mortality during the pandemic and compares it to previous influenza seasons. Excess mortality refers to the number of deaths above what would normally be expected based on historical data. The pandemic caused a significant spike in excess mortality, particularly in 2020 and 2021, contributing to the temporary reduction in overall life expectancy. The data underscores the importance of robust public health infrastructure and effective pandemic preparedness measures.
Regional Disparities and Socioeconomic Factors
The stark contrast in life expectancy between regions within Europe highlights the influence of socioeconomic factors. Regions with higher levels of income, education, and access to quality healthcare tend to have longer life expectancies. Conversely, areas grappling with poverty, unemployment, and limited access to essential services often experience lower longevity rates. Addressing these socioeconomic disparities is crucial for improving population health and reducing inequalities in life expectancy. Lifestyle factors such as diet, exercise, and smoking habits also play a significant role in determining individual and regional longevity.
Looking Ahead: Trends and Challenges
While Europe has made considerable progress in increasing life expectancy, several challenges remain. An aging population places increasing strain on healthcare systems and social security programs. The rise of chronic diseases, such as heart disease, cancer, and diabetes, also poses a significant threat to population health. Addressing these challenges requires a multi-faceted approach, including investments in preventative care, promotion of healthy lifestyles, and development of innovative healthcare technologies. Continued monitoring of life expectancy trends and analysis of regional disparities are essential for informing evidence-based policies and ensuring a healthy future for all Europeans.
The ongoing efforts to combat infectious diseases, such as influenza and COVID-19, through vaccination programs and public health measures will also be critical in maintaining and improving life expectancy. The development and approval of combined mRNA vaccines, as recently recommended by European regulators, represent a significant step forward in protecting populations from multiple threats simultaneously.
As populations age and healthcare demands increase, innovative solutions will be needed to ensure sustainable and equitable access to care. This includes exploring new models of healthcare delivery, leveraging digital technologies, and fostering greater collaboration between healthcare providers, researchers, and policymakers. The future of longevity in Europe depends on a collective commitment to investing in the health and well-being of all citizens.
The European Commission is expected to release updated demographic projections in late 2026, providing further insights into the evolving trends in life expectancy and population aging. These projections will be crucial for informing long-term planning and policy development across the continent. Stay informed about these developments and contribute to the conversation by sharing your thoughts and experiences in the comments below.